Annual MalariaGEN Genomic Epidemiology of Malaria Conference

Held at the Wellcome Trust Conference Centre, Genome Campus, Hinxton, UK, the Genomic Epidemiology of Malaria (GEM) conference provides a forum for malaria scientists and clinicians working at the interface of genome science and technology, clinical epidemiology, and statistical epidemiology and genetics, who are interested in understanding the clincial and biological consequences of genome variation in malaria-exposed populations. It is the only meeting of its kind worldwide in a burgeoning field poised to make a real impact on the understanding, treatment and prevention of malaria.

GEM Conference Scientific Organising Committee

GEM Conference Scientific Organising Committee [Genome Research Limited]

zoom

Since its inception in 2008, the GEM conference has quickly become a catalyst and cornerstone meeting in this field, attracting the attendance of leaders from around the world. Distinctive features of the GEM conference include:

  • Participation of leading international scientists in all three malaria-relevant genomes (parasite, mosquito and human) with sessions on cross-cutting issues to encourage scientific interaction and to get at biological interaction.
  • Focus on public health applications of the research, such as surveillance of genome variation in natural parasite and mosquito populations to monitor anti-malarial drug resistance and insecticide resistance.
  • In-depth discussion about the issues and applications of current and emerging sequencing technology, which will underpin the progress of genomic epidemiology research.
  • Strong representation from leading scientists and clinicians from malaria-endemic regions.

Objectives of the GEM Conference

There are two principal objectives of the GEM Conference:

Residence Locations of Conference Delegates

Residence Locations of Conference Delegates [Genome Research Limited]

zoom

  1. To identify opportunities for the application of current and emerging genome sequencing and genotyping technology in understanding the genetic underpinnings of immunity and susceptibility to malaria in humans, anti-malaria drug resistance in parasites, and insecticide resistance in mosquitoes.
  2. To foster interactions and partnership between relevant communities who share this goal: between researchers working independently in each of the malaria-relevant genomes (malaria, mosquito, and human); between scientists of malaria-endemic regions and the developed world; and between malaria scientists and other stakeholders including technologists and funders.

"Unique insights and contributions from researchers working in malaria-endemic regions of the world are key to the success of the GEM meeting"

This conference is recognised in the field as a unique opportunity for scientists from leading genome research programmes to engage and foster collaborations with scientists and clinicians working in malaria-endemic regions. Furthermore, it provides a forum to allow delegates to discuss issues directly related to partnership and capacity building in malaria-endemic countries, including scientific and social issues related to collaboration and network development, training and infrastructure, data sharing, and career development.

The GEM Conference is held annually over three days in June and is attended by over 100 delegates. We run a poster session for those not giving longer talks, which allows the poster presenter to give a one-minute talk with a slide on their research. In addition, we organise various social events, which in the past have included a 'Science Speed Dating' session, whisky tasting and an African live band.

Unique insights and contributions from researchers working in malaria-endemic regions of the world are key to the success of the GEM meeting and to the progress of this field in general and therefore we seek to find funding to allow scientists from developing countries to attend the conference. These delegates have previously been fully sponsored to attend the conference through organisations such as the Bill and Melinda Gates Foundation or the Burroughs Wellcome Fund.

* quick link - http://q.sanger.ac.uk/fl4lko76